Kineta finalizes reverse merger with Yumanity, secures additional funding

Seattle-based biotech Kineta Inc. has completed its reverse merger with Boston-based biotech Yumanity Therapeutics Inc. The Seattle-based biotech says that with the new funding it expects to have runway through mid-2024.